Little Rock Hematology Oncology: A Division of CARTI — Little Rock, Arkansas

Little Rock Hematology Oncology: A Division of CARTI is a clinical research site located in Little Rock, Arkansas, United States 72205.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Little Rock Hematology Oncology: A Division of CARTI has participated in 1 clinical trials.

Therapeutic areas: Advanced Prostate Cancer, Prostatic Neoplasms.

Sponsors: Dendreon.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Little Rock Hematology Oncology: A Division of CARTI?

Little Rock Hematology Oncology: A Division of CARTI has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Little Rock Hematology Oncology: A Division of CARTI conducted?

Little Rock Hematology Oncology: A Division of CARTI has 1 clinical trials on record. Their work covers Advanced Prostate Cancer, Prostatic Neoplasms.

Is Little Rock Hematology Oncology: A Division of CARTI accredited by Crixeo Health?

Little Rock Hematology Oncology: A Division of CARTI has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Little Rock Hematology Oncology: A Division of CARTI?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.